Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on July 22, 2015, primarily to announce its financial results for the fiscal quarter ended June 27, 2015. The filing incorporates by reference a press release detailing these results, which are crucial for investors to assess the company's recent performance and financial health. While the specific financial figures are in the referenced press release, this 8-K serves as the official notification to the market. Beyond financial results, the 8-K also disclosed a significant executive leadership change. Peter M. Wilver, previously the Senior Vice President and Chief Financial Officer, has been appointed Executive Vice President and Chief Administrative Officer, effective August 1, 2015. This move indicates a shift in executive responsibilities and ensures Mr. Wilver's continued tenure with the company, addressing prior reports of his potential retirement. Stephen Williamson will succeed Mr. Wilver as the new CFO.
Key Highlights
- 1Announcement of Q2 2015 financial results via press release dated July 22, 2015.
- 2Peter M. Wilver appointed Executive Vice President and Chief Administrative Officer, effective August 1, 2015.
- 3Mr. Wilver will not retire in March 2016 as previously indicated.
- 4Mr. Wilver's new role will encompass global business services, human resources, and legal functions.
- 5Stephen Williamson to succeed Peter M. Wilver as Senior Vice President and Chief Financial Officer on August 1, 2015.
- 6The press release containing financial results is furnished as an exhibit and not considered 'filed' under Section 18 of the Exchange Act.